McKesson Makes $2.5 Billion Move To Expand Its Platform
Precision Medicine Group will become part of McKesson’s Oncology & Multispecialty segment once the transaction is completed. The deal remains subject to regulatory approval and other customary closing requirements. McKesson has not announced an anticipated closing date.

